Genetics of complex diseases; mendelian randomisation and causality of disease; plasmabiomarkers and prediction of life-style diseases and rare diseases; life-style and risk of disease; large scale pharmacoepidemiology and epidemiolgical disease interaction.

Statin use and off-target outcomes; genetics of breast, prostate and ovarian and rare cancer; common and rare genetic variation and risk of cardio-metabolic disease and hypertension; lifestyle and risk of allergy; biomarkers and risk of COPD, allergy, infection, autoimmune disease, cardiovascular disease, venous thromboembolism, microvascular disease.

Complement C3 and risk of lifestyle disease; statin use and acute kidney injury; smoking and risk of allergic disease; Eosinophils and risk of COPD, asthma and infectious disease.

none